Talis Biomedical | 10-Q: Quarterly report

Futu NewsMay 8 20:08 · Announcements

Talis Biomedical Secures Interim CFO Amidst Corporate Changes

TipRanksApr 12 05:02

Talis Biomedical Q4 EPS $(7.39) Up From $(15.15) YoY, Sales $195.00K Down From $257.00K YoY

Talis Biomedical (NASDAQ:TLIS) reported quarterly losses of $(7.39) per share. This is a 51.22 percent increase over losses of $(15.15) per share from the same period last year. The company reported

BenzingaMar 29 11:28

Talis Biomedical Ends Role of President Amid Reorganization

TipRanksJan 27 17:25

Why Talis Biomedical (TLIS) Stock Is Exploding Higher

Talis Biomedical Corp (NASDAQ:TLIS) shares are trading higher by 30% to $7.03 Tuesday morning after the company announced it is exploring strategic options to boost shareholder value due to current ma

BenzingaNov 15, 2023 01:21

Talis Reviewing Strategic Alternatives, Stock Rallies 35%

Seeking AlphaNov 15, 2023 00:03